Real-world depression, anxiety and safety outcomes of intramuscular ketamine treatment: a retrospective descriptive cohort study

BACKGROUND: Ketamine has emerged as a promising pharmacotherapy for depression and other mental illnesses, and the intramuscular (IM) administration of ketamine is now offered at many North American outpatient psychiatric clinics. However, a characterization of the outpatient population receiving IM...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahuja, Sachin, Brendle, Madeline, Smart, Leo, Moore, Claire, Thielking, Paul, Robison, Reid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528178/
https://www.ncbi.nlm.nih.gov/pubmed/36192794
http://dx.doi.org/10.1186/s12888-022-04268-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9528178/
https://www.ncbi.nlm.nih.gov/pubmed/36192794
http://dx.doi.org/10.1186/s12888-022-04268-5

Ejemplares similares